BMS-911543, a promising anticancer agent, exhibited time-dependent and dose-dependent nonlinear pharmacokinetics (PKs) in its first-in-human (FIH) study. Initial physiologically based pharmacokinetic (PBPK) modeling efforts using CYP1A2-mediated clearance kinetics were unsuccessful; however, further model analysis revealed that CYP1A2 time-dependent inhibition (TDI) and perhaps other factors co...

Adaptations to change in oxygen availability are crucial for survival of multi-cellular organisms and are also implicated in several disease states. Such adaptations rely upon gene expression regulated by the heterodimeric transcription factors HIFs (hypoxia-inducible factors). Enzymes that link changes in oxygen tensions with the stability and transcriptional activity of HIFs are considered as...

The JmjC histone lysine demethylases (KDMs) are epigenetic regulators involved in the removal of methyl groups from post-translationally modified lysyl residues within histone tails, modulating gene transcription. These enzymes require molecular oxygen for catalytic activity and, as 2-oxoglutarate (2OG)-dependent oxygenases, are related to the cellular oxygen sensing HIF hydroxylases PHD2 and F...

!" #%$ & ' ( )+*, .# / .021"3& 4 5 "#% 6$/ 7 8 #% 9 : ; 7 . <09# = : 6 77 $ ?> & 5# , : ? . & # $@ A3& B 8 =)DCE# ? &3& & 2 .021 : F: G$@ & & H 8 I 2 G H3& E & #% / 7 3 & F I ")KJ6 L & M & N : K I ? D$@ " & 73 $@ 8 F K ! :,1 OP: 3 : : K$@# :G & 2 . & &1Q " & 73 $@ 8 G$20 P3&#% &3 # R# 6 7 7 $ " & &1K S T 4$@ B UO & R & 2 . &1K ! & 7 & 2 : ( L I #% $@ B UO & R : & V)S S R : & 7 ( 73& & #% $@ 3&#...

Cell adaptation to changes in oxygen (O(2)) availability is controlled by two subfamilies of O(2)-dependent enzymes: the hypoxia inducible factor (HIF)-prolyl and asparaginyl hydroxylases [prolyl hydroxylases domain (PHDs) and factor inhibiting HIF (FIH)]. These oxygen sensors regulate the activity of the HIF, a transcriptional complex central in O(2) homeostasis. In well oxygenated cells, PHDs...

This issue of the Journal of Pharmacological and Toxicological Methods (JPTM) is themed. It is the eighth in a series, arising from the Annual Safety Pharmacology Society (SPS) meeting. The SPS is now in its 10th year as an independent branch of biological sciences (distinct from pharmacology and toxicology) and is the primary forum for driving advances in safety pharmacology. The theme of the ...

INTRODUCTION In 1999, the NIH Recombinant DNA Advisory Committee held a Gene Therapy Policy Conference on in utero gene transfer (NIH, 1999) and determined that it would be premature to undertake in utero gene transfer research in humans (RAC, 1999). Much has happened since then. Gene transfer research enrolling infants and very young children as patient-subjects has had results both beneficial...